Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Johnson_&_Johnson
|
| gptkbp:contributedTo |
medical research
|
| gptkbp:employs |
researchers
scientists clinical trial specialists |
| gptkbp:founded |
1979
|
| gptkbp:founder |
Dr. Paul J. McGowan
|
| gptkbp:has_a |
pharmaceutical markets
|
| gptkbp:has_a_focus_on |
patient education
biomarkers clinical guidelines oncology personalized medicine autoimmune diseases infectious diseases treatment protocols genomic research inflammatory diseases clinical efficacy healthcare_access |
| gptkbp:has_a_mission_to |
improve patient outcomes
|
| gptkbp:has_partnerships_with |
various research institutions
healthcare_providers |
| gptkbp:headquarters |
gptkb:Malvern,_Pennsylvania
|
| https://www.w3.org/2000/01/rdf-schema#label |
Centocor
|
| gptkbp:is_a_member_of |
pharmaceutical associations
biotechnology associations |
| gptkbp:is_committed_to |
patient safety
sustainability ethical practices corporate responsibility |
| gptkbp:is_involved_in |
clinical trials
community outreach programs patient advocacy healthcare_policy_advocacy |
| gptkbp:is_known_for |
gptkb:Simponi
patient-centered care scientific publications market leadership research collaborations patient support programs clinical research initiatives Remicade Stelara therapeutic advancements drug development pipelines therapeutic areas of expertise healthcare_innovation healthcare_solutions |
| gptkbp:is_recognized_for |
innovation in biotechnology
|
| gptkbp:leadership |
biopharmaceutical development
|
| gptkbp:operates_in |
healthcare industry
|
| gptkbp:produces |
therapeutic antibodies
|
| gptkbp:receives |
numerous awards
FDA_approvals |
| gptkbp:specializesIn |
biopharmaceuticals
|
| gptkbp:subsidiary |
gptkb:Centocor_Ortho_Biotech_Inc.
|